HVEM signaling promotes protective antibody-dependent cellular cytotoxicity (ADCC) vaccine responses to herpes simplex viruses is a research paper published in Science Immunology (2020). On theSindex it has a DataRank of 0. It has been cited 25 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01 AI067890
Howard Hughes Medical Institute
Grant: International Student Research Fellowship
National Cancer Institute
Grant: P01 CA177322
National Cancer Institute
Grant: R01 CA198095
National Cancer Institute
Grant: P30 CA013330
National Institute of Allergy and Infectious Diseases
Grant: R01 AI134824
NIAID
Grant: R01 AI 17321-01
NIAID NIH HHS
Grant: R37 AI026170
NIAID NIH HHS
Grant: R01 AI117321
NIGMS NIH HHS
Grant: R25 GM104547
National Institutes of Health
Grant: 2R01AI067890-07A1
HVEM-BTLA system in Inflammation
National Institutes of Health
Grant: 6R01AI134824-03
Host-virus interactions in the control of filovirus entry
National Institutes of Health
Grant: 5P01CA177322-03
Innate Immune Responses and Vaccines Against Tumor-Associated Herpesviruses
FWCI
1.64
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Development of a highly effective combination monoclonal antibody therapy against Herpes simplex virus
Additional file 1 of Development of a highly effective combination monoclonal antibody therapy against Herpes simplex virus